Oisin Biotechnologies has a total of 40 patents globally, out of which 6 have been granted. Of these 40 patents, more than 62% patents are active. The USA is where Oisin Biotechnologies has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, the USA seems to be the main focused R&D center of Oisin Biotechnologies and is also the origin country of the firm.
Oisin Biotechnologies was founded in the year 2014 by Garry Hudson, Kevin Perrott and Matthew Scholz. The company is a drug development firm focused on mitigating the senolytic technology to combat age-related diseases.
Do read about some of the most popular patents of Oisin Biotechnologies which have been covered by us in this article and also you can find Oisin Biotechnologies patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Oisin Biotechnologies patent portfolio.
How many patents does Oisin Biotechnologies have?
Oisin Biotechnologies has a total of 40 patents globally. These patents belong to 5 unique patent families. Out of 40 patents, 25 patents are active.
How Many Patents did Oisin Biotechnologies File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Oisin Biotechnologies Applications Filed | Oisin Biotechnologies Patents Granted |
| 2022 | 3 | 1 |
| 2021 | 2 | 3 |
| 2020 | 3 | – |
| 2019 | 8 | – |
| 2018 | 8 | – |
| 2017 | – | – |
| 2016 | 1 | – |
| 2015 | 4 | – |
| 2014 | 11 | – |
How many Oisin Biotechnologies patents are Alive/Dead?
Worldwide Patents
How Many Patents did Oisin Biotechnologies File in Different Countries?
Countries in which Oisin Biotechnologies Filed Patents
| Country | Patents |
| United States Of America | 8 |
| Australia | 4 |
| Europe | 4 |
| China | 3 |
| Canada | 3 |
| Korea (South) | 3 |
| India | 3 |
| Japan | 2 |
| Mexico | 2 |
| Brazil | 1 |
| Hong Kong (S.A.R.) | 1 |
| New Zealand | 1 |
Where are Research Centres of Oisin Biotechnologies Patents Located?
The R&D Centre of Oisin Biotechnologies is in the United States.
10 Best Oisin Biotechnologies Patents
US20200009268A1 is the most popular patent in the Oisin Biotechnologies portfolio. It has received 10 citations so far from companies like Seed Health.
Below is the list of 10 most cited patents of Oisin Biotechnologies:
| Publication Number | Citation Count |
| US20200009268A1 | 10 |
| WO2018129563A1 | 9 |
| US20160010110A1 | 8 |
| CN105518149A | 3 |
| CN110678208A | 2 |
| WO2020163408A3 | 2 |
| WO2019204666A1 | 2 |
| US11525146B2 | 1 |
| CN112312918A | 1 |
| US20160051700A1 | 1 |
List of Oisin Biotechnologies Patents
| Oisin Biotechnologies Patents | Title |
| US11603543B2 | Fusogenic Lipid Nanoparticles For Target Cell-Specific Production Of A Therapeutic Protein |
| US11525146B2 | Expression Constructs, Fusogenic Lipid-Based Nanoparticles And Methods Of Use Thereof |
| US20230348937A1 | Fusogenic Lipid Nanoparticles For Target Cell-Specific Production Of A Therapeutic Protein Fusogenic Lipid Nanoparticles And Methods Of Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease |
| US20230220422A1 | Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell |
| US20220106608A1 | Fusogenic Lipid Nanoparticles For The Target Cell-Specific Production Of Rapamycin Inducible Therapeutic Proteins |
| US20200009268A1 | Expression Constructs And Systems For Systemic And Non-Specific In Vivo Delivery Of A Nucleic Acid To Human Cells And Transient Target Cell-Specific Production Of A Therapeutic Protein |
| EP3920888A4 | Fusogenic Lipid Nanoparticles For The Target Cell-Specific Production Of Rapamycin Inducible Therapeutic Proteins |
| EP3784252A4 | Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell |
| EP3565607A4 | Fusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment |
| EP2978854A4 | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| CN112312918A | Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell |
| CN110678208A | Fusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment |
| WO2023056070A3 | Compositions And Methods For Liver-Specific Expression Of Follistatin |
| AU2018220160B2 | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| AU2018206485A1 | Fusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment |
| CA2940123C | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| CA3097411A1 | Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell |
| CA3047140A1 | Constructs For Expression Of Therapeutic Proteins In Target Cells |
| HK1218935A | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| JPWO2019204666A5 | Fusogenic Lipid Nanoparticles And Methods Of Producing Fusogenic Lipid Nanoparticles For Target Cell-Specific Production Of Therapeutic Proteins And Treatment Of Target Cell-Related Diseases, Conditions, Or Disorders And How To Use |
| MX387916B | Expression Construct For Transient Production Of A Casp9 Therapeutic Protein In A Senescent Human Target Cell. |
| MX387280B | System For Targeted Production Of A Therapeutic Protein Within A Target Cell And Use Of The System. |
| IN202018041801A | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| IN201917027258A | Fusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment |
| NZ713639A | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| US20160051700A1 | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| US20160010110A1 | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| CN105518149A | Systems And Methods For The Targeted Production Of Therapeutic Protein Within Target Cell |
| WO2020163408A3 | Fusogenic Lipid Nanoparticles For The Target Cell-Specific Production Of Rapamycin Inducible Therapeutic Proteins |
| WO2019204666A1 | Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell |
| WO2018129563A1 | Fusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment |
| WO2014160661A3 | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| AU2021200496A1 | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| AU2014241622A1 | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| JP2020503390A5 | Fusogenic Lipid Nanoparticles And Methods For Their Production And Use For Target Cell-Specific Production Of Therapeutic Proteins And Treatment Of Diseases, Conditions, Or Disorders Associated With Target Cells |
| KR1020200074283A | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| KR1020180118259A | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| BR112015024605A2 | Systems And Methods For The Targeted Production Of Therapeutic Protein Within A Target Cell |
| IN9955DELNP2015A | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
| KR1020160002848A | Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell |
What are Oisin Biotechnologies’ key innovation segments?
What Technologies are Covered by Oisin Biotechnologies?
The chart below distributes patents filed by Oisin Biotechnologies